Ferritin, C‐Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH
American Journal of Hematology · 2025
DOI: 10.1002/ajh.70081 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Steven Rowe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. Hauptthemen laut MEDLINE: C-Reactive Protein, Ferritins, Interleukin-2 Receptor alpha Subunit, Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: United States Food and Drug Administration, NHLBI NIH HHS, Castleman Disease Collaborative Network.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
- Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.
- Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
- Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Pathology, University of Utah, Salt Lake City, Utah, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA.
ORCID-Profile: Steven Rowe, Mariam Goubran, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Junyan Shi, Lisa K Peterson, Joshua D Brandstadter, David C Fajgenbaum, Luke Y C Chen
Förderung
- United States Food and Drug Administration
- NHLBI NIH HHS
- Castleman Disease Collaborative Network
- FDA HHS
- Hsu & Taylor Family through the VGH & UBC Hospital Foundation and the Nova Scotia Health Innovation Hub
- Recordati Rare Diseases
- The Colton Center for Autoimmunity at the University of Pennsylvania
- National Heart, Lung, and Blood Institute
Zitieren
APA
Rowe, S., Goubran, M., Sarmiento Bustamante, M., Shyamsundar, S., Austin, B., McNicholas, K., Blommers, M., Shi, J., Peterson, L. K., Sepiashvili, L., Mattman, A., Brandstadter, J. D., Fajgenbaum, D. C., & Chen, L. Y. C. (2025). Ferritin, C‐Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH. American Journal of Hematology. https://doi.org/10.1002/ajh.70081
Vancouver
Rowe S, Goubran M, Sarmiento Bustamante M, Shyamsundar S, Austin B, McNicholas K, et al. Ferritin, C‐Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH. American Journal of Hematology. 2025. doi:10.1002/ajh.70081
BibTeX
@article{Rowe2025,
author = {Rowe, Steven and Goubran, Mariam and Sarmiento Bustamante, Mateo and Shyamsundar, Saishravan and Austin, Bridget and McNicholas, Kathleen and Blommers, Marley and Shi, Junyan and Peterson, Lisa K and Sepiashvili, Lusia and Mattman, Andre and Brandstadter, Joshua D and Fajgenbaum, David C and Chen, Luke Y C},
title = {Ferritin, C‐Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.70081}
}
EUVIMED